VOA ASIA Business Scene 20180726 UMN

China’s drug industry is in trouble as yet another scandal hits it. This time the scandal involves a rabies vaccine made by one of the country’s biggest pharmaceutical companies, Changchun Changsheng Biotechnology. Soybean importers in China are quickly adapting to the new tariffs on U.S. soybeans, looking for alternative markets and switching to other substitutes whenever possible.